Optimus Pharma

Optimus Pharma is a leading Indian pharmaceutical manufacturer specializing in active pharmaceutical ingredients (APIs), intermediates, and finished dosage formulations. The company has received regulatory approvals from agencies such as USFDA, EU-GMP, WHO, TGA, KFDA, COFEPRIS. It has developed over 35 API products and more than 20 FDF products with global market presence across more than 40 countries. Recent highlights include emergency use authorization for molnupiravir in India during the COVID pandemic, participation in the Production Linked Incentive scheme for pharmaceuticals, and an agreement with Medicines Patent Pool to supply low-cost molnupiravir to low-and-middle-income countries. The company was acquired by Sekhmet Pharmaventures in May 2022.